Régnier Denois, Véronique http://orcid.org/0000-0002-0293-5606
Bourmaud, Aurelie
Nekaa, Mabrouk
Bezzaz, Céline
Bousser, Véronique
Kalecinski, Julie
Dumesnil, Julia
Tinquaut, Fabien
Berger, Dominique
Chauvin, Franck
Funding for this research was provided by:
canceropole Auvergne Rhône-Alpes
Article History
Received: 22 November 2017
Revised: 12 April 2018
Accepted: 9 May 2018
First Online: 28 May 2018
Compliance with ethical standards
:
: All procedures performed in this study were in accordance with ethical standards. The study has been declared with the French National Commission on Information Technology and Liberties (CNIL No. 1688834v0). The relevant ethics committee (CHU–St Etienne) has delivered its favorable opinion on the investigation plan (IRBN 602015/CHUSTE).
: Véronique Régnier Denois declares that she has no conflict of interest. Aurelie Bourmaud received non-financial support and research travel cover from Abbie Pharmaceuticals. Mabrouk Nekaa declares that he has no conflict of interest. Céline Bezzaz declares that she has no conflict of interest. Véronique Bousser declares that she has no conflict of interest. Julie Kalecinski declares that she has no conflict of interest. Julia Dumesnil declares that she has no conflict of interest. Fabien Tinquaut declares that he has no conflict of interest. Dominique Berger declares that he has no conflict of interest. Franck Chauvin declares that he has no conflict of interest. All authors declare that they have no conflict of interest or financial relationship with the organization that sponsored the research.
: In accordance with ethical approval requirements, individual informed consent was not required for the children. An agreement has been signed with the National Education administration. Information about the study was given to the participating school inspector and school leaders, as well as to the teaching team, parents and children involved.